دورية أكاديمية
Hepatitis C: sociodemographic and clinical profile of patients treated with direct-acting antivirals in a pharmaceutical office
العنوان: | Hepatitis C: sociodemographic and clinical profile of patients treated with direct-acting antivirals in a pharmaceutical office |
---|---|
المؤلفون: | Karem Aline Pegoraro, Edson Luiz Folador, Dennis Armando Bertolini, Angela Maria Campagna |
المصدر: | Acta Scientiarum. Health Sciences, Vol 45, Iss 1 (2023) |
بيانات النشر: | Universidade Estadual de Maringá, 2023. |
سنة النشر: | 2023 |
المجموعة: | LCC:Medicine (General) LCC:Pharmacy and materia medica |
مصطلحات موضوعية: | HCV, antivirals agents, direct-acting antivirals, pharmaceutical services, genotype., Medicine (General), R5-920, Pharmacy and materia medica, RS1-441 |
الوصف: | To report the sociodemographic and clinical profile of patients treated with direct-action antivirals (DAAs). Patients infected with hepatitis C virus in current treatment were followed up in a pharmaceutical office. Sociodemographic, clinical and medicines uses characteristics were obtained. A total of 62 patients were enrolled, with a higher proportion of men, aged between 40 and 69 years, low schooling, and workers. Were predominant the HCV virus genotype 1 (45.2%) and 3 (48.4%), and 19.4% were cirrhotic. Of the referred comorbidities, stood out those diseases related to the cardiovascular system (19.8%), psychiatric disorders (17.6%), endocrine and metabolic disorders (14.5%). Co-infections represented 5.2%, and were distributed between acute hepatitis A (1.0%), chronic viral hepatitis B (2.1%), and HIV (2.1%). Previous or current use of licit / illicit substances was reported by 33.9% of patients. A significant difference was identified in the youngest age group (25 to 39 years, p = 0.02), with a lower average viral load compared to the other age groups. The pharmacotherapeutic follow-up carried out in the period resulted in 157 pharmaceutical consultations. Patients with hepatitis C using DDAs were mostly men, aged between 40 and 69 years. Type 3 HCV genotype was most frequently identified. The presence of cirrhosis and other comorbidities serves as an alert for health professionals in the implementation of public health policies. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English Portuguese |
تدمد: | 1679-9291 1807-8648 |
العلاقة: | https://periodicos.uem.br/ojs/index.php/ActaSciHealthSci/article/view/62343Test; https://doaj.org/toc/1679-9291Test; https://doaj.org/toc/1807-8648Test |
DOI: | 10.4025/actascihealthsci.v45i1.62343 |
الوصول الحر: | https://doaj.org/article/b3e49827c3fb4e459b577dceebfc8cffTest |
رقم الانضمام: | edsdoj.b3e49827c3fb4e459b577dceebfc8cff |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 16799291 18078648 |
---|---|
DOI: | 10.4025/actascihealthsci.v45i1.62343 |